Lonza Signs Manufacturing Deal with Biopharma Firm

14:44 PM | June 29, 2009

Lonza says it has signed a deal to produce therapeutic monoclonal antibody Anthim for biopharmaceutical company Elusys Therapeutics (Pine Brook, NJ). Anthim, which is in late-stage development, can be...